Postmenopausal hormone replacement therapy use associated with increased ovarian cancer risk
1. In this meta-analysis of postmenopausal women with ovarian cancer, the risk of ovarian cancer was strongly associated with recent ...
1. In this meta-analysis of postmenopausal women with ovarian cancer, the risk of ovarian cancer was strongly associated with recent ...
1. In a retrospective review of over 600 patients with ovarian cancer, preoperative disease burden was the single most significant ...
Originally published by Harvard Health. What Is It? Ovarian cancer is the uncontrolled growth of abnormal cells in the ovaries. ...
1. In a small study of five women, vaginal DNA from tampons had a 60% sensitivity for detecting high-grade serous ...
1. Ultrasound- or computed tomography (CT)-guided ovarian mass biopsy yielded diagnostically sufficient samples with a sensitivity and specificity of 100% ...
1. A non-randomized control trial of 996 women at high risk for developing ovarian and tubal cancer found that 2.6% ...
1. Ovarian cancer patients randomized to receive paclitaxel + trebananib had improved progression-free survival versus paclitaxel + placebo. 2. Patients ...
Image: PD 1. Combining bevacizumab with standard chemotherapy improved progression free survival and objective response rate in platinum-resistant ovarian cancer. ...
Image: PD 1. Women who used oral contraceptive pills (OCPs) were at a significantly lower risk of developing ovarian cancer ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.